OppenheimerFunds’s Cantel Medical Corporation CMD Stock Holding History

OppenheimerFunds’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$358K	Buy	+5,354	New	+$405K	﹤0.01%	1491
2018 Q4	–	Sell	-173,535	Closed	-$16M	–	1881
2018 Q3	$16M	Sell	173,535 -241,775	-58%	-$23M	0.02%	641
2018 Q2	$40.9M	Sell	415,310 -539	-0.1%	-$60.3K	0.05%	379
2018 Q1	$46.3M	Buy	415,849 +30,051	+8%	+$3.37M	0.06%	332
2017 Q4	$39.7M	Buy	385,798 +13,106	+4%	+$1.31M	0.05%	378
2017 Q3	$35.1M	Sell	372,692 -50,731	-12%	-$4M	0.04%	395
2017 Q2	$33M	Sell	423,423 -79,854	-16%	-$6M	0.04%	408
2017 Q1	$40.3M	Buy	503,277 +51,638	+11%	+$4.1M	0.05%	366
2016 Q4	$35.6M	Sell	451,639 -85,777	-16%	-$6.67M	0.05%	401
2016 Q3	$41.9M	Sell	537,416 -80,542	-13%	-$5.84M	0.05%	375
2016 Q2	$42.5M	Buy	617,958 +34,918	+6%	+$2.41M	0.06%	348
2016 Q1	$41.6M	Buy	583,040 +38,434	+7%	+$2.41M	0.06%	354
2015 Q4	$33.8M	Sell	544,606 -18,477	-3%	-$1.13M	0.04%	422
2015 Q3	$31.9M	Buy	563,083 +74,660	+15%	+$3.95M	0.04%	428
2015 Q2	$26.2M	Buy	488,423 +24,900	+5%	+$1.21M	0.03%	516
2015 Q1	$22M	Buy	463,523 +31,010	+7%	+$1.37M	0.02%	567
2014 Q4	$18.7M	Buy	432,513 +60,800	+16%	+$2.48M	0.02%	603
2014 Q3	$12.8M	Buy	371,713 +48,360	+15%	+$1.71M	0.01%	689
2014 Q2	$11.8M	Buy	323,353 +136,550	+73%	+$4.63M	0.01%	734
2014 Q1	$6.3M	Buy	+186,803	New	+$6.16M	0.01%	819

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

OppenheimerFunds's CMD Position: Q1 2019 in Review

OppenheimerFunds opened a new position in Cantel Medical Corporation (CMD) in Q1 2019: 5,354 shares worth $358K. The stake represents ﹤0.01% of the portfolio and ranks #1491 among its holdings. This is a return to the name: OppenheimerFunds previously reported a position in CMD as recently as Q3 2018.

OppenheimerFunds first reported a position in CMD in Q1 2014 and has held it in 20 quarters since. The position peaked at $46.3M in Q1 2018. 254 funds tracked by Wall St. Rank hold CMD as of Q1 2019.

OppenheimerFunds held 5,354 shares of Cantel Medical Corporation worth $358K as of Q1 2019.
Cantel Medical Corporation was a new OppenheimerFunds position in Q1 2019.
Cantel Medical Corporation made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1491 holding.
OppenheimerFunds first reported a position in Cantel Medical Corporation in Q1 2014 and has held it in 20 quarters since.
OppenheimerFunds's Cantel Medical Corporation position peaked at $46.3M in Q1 2018.
254 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.